Skip to main content
Earnings Labs
Prime Medicine, Inc. logo

Prime Medicine, Inc. (PRME)

NASDAQ·Healthcare·Biotechnology

$3.14

-11.58%

Mkt Cap $563.53M

Analyst Ratings

Buy

4

Hold

0

Sell

0

Price Target (6 analysts)

$7.00

Range $6.00$8.00

Implied Upside

+123.3%

Consensus $7.00 vs current $3.14